A biopharma speciality medicines expert within government affairs and policy, market access, patient engagement and communications.
Jamie is a recognised biopharma speciality medicines expert within healthcare government affairs and policy, market access pathways, patient engagement and communications.
He has been at the forefront of ensuring patient access to innovation for over 20 years, assisting numerous high-profile corporations on landscape analysis and influence, commercialisation of innovative therapies, stakeholder engagement, reimbursement strategy and communications management.
Originally a journalist and media relations advisor to MPs and Ministers, Jamie established a dedicated healthcare policy and public affairs consultancy in 2006 advising industry, patient groups and medical professional bodies on how to engage and influence the policy environment. Notable projects and clients included Alexion, Bayer, CSL Behring and the Genetic Alliance.
He was Head of Government Affairs for Vertex Pharmaceuticals (Northern Europe) from 2016 and the Director of International Patient Engagement for Vertex on their joint venture with CRISPR Therapeutics from 2019-21.
He has academic and professional qualifications from Liverpool John Moores University, Oxford University and the Wharton School of the University of Pennsylvania.
Jamie provides consultancy on a project, contract, or retainer basis to support patient access to innovative therapies in the UK and EU.
Biopharma companies, the unmet need of the patients they serve and the environments they operate in are all by definition unique and require a bespoke approach.
Typical services include: